Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120484 · ClinicalTrials.gov registry record · NA
Effects of Vitamin B12 on the Body's Internal Clock
A NA study of Sleep Disorders, Circadian Rhythm, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00120484 is a NA study of Sleep Disorders, Circadian Rhythm that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 10 participants, below the 62-participant average among 4 other Sleep Disorders, Circadian Rhythm trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00120484, a NA study of Sleep Disorders, Circadian Rhythm, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Circadian rhythms are 24-hour cycles that influence natural functions in the body such as heart rate, blood pressure, and body temperature. Circadian rhythms provide the body with an internal clock and affect sleep patterns. The purpose of this study is to determine the effects of vitamin B12 supplements on circadian rhythms and sleep-wake regulation.
Conditions Studied
Interventions
- DRUG Vitamin B12
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital, Harvard Medical School - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-04 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120484
The ClinicalTrials.gov registry entry for NCT00120484 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 4 other Sleep Disorders, Circadian Rhythm trials with a reported enrollment target (84% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sleep Disorders, Circadian Rhythm appearing as the primary indexed condition, and to 1 intervention - of which Vitamin B12 is the first listed.
NCT00120484 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00120484 about?
NCT00120484 is a clinical study titled "Effects of Vitamin B12 on the Body's Internal Clock". Circadian rhythms are 24-hour cycles that influence natural functions in the body such as heart rate, blood pressure, and body temperature. Circadian rhythms provide the body with an internal clock and affect sleep patterns. The purpose of this study is to determine the effects of vitamin B12 supple...
What is the current status of trial NCT00120484?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2005-04. Estimated completion is 2008-01.
What conditions does trial NCT00120484 study?
This clinical trial studies the following conditions: Sleep Disorders, Circadian Rhythm.
What interventions are being tested in trial NCT00120484?
The interventions under investigation include: Vitamin B12 (DRUG).
Who is sponsoring clinical trial NCT00120484?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00120484 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorders, Circadian Rhythm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment
COMPLETED · NA
-
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
RECRUITING · Phase 3
-
Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome
COMPLETED · Phase 2
-
Treatment Strategies for Children With Smith-Magenis Syndrome
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.